US 11,938,291 B2
System and method for reducing pulsatile pressure
John Scandurra, St. Paul, MN (US); and Karl Vollmers, Minneapolis, MN (US)
Assigned to Aria CV, Inc., St. Paul, MN (US)
Filed by Aria CV, Inc., St. Paul, MN (US)
Filed on Aug. 1, 2022, as Appl. No. 17/816,534.
Application 17/816,534 is a continuation of application No. 16/989,830, filed on Aug. 10, 2020, granted, now 11,406,803, issued on Aug. 9, 2022.
Application 16/989,830 is a continuation of application No. 14/955,109, filed on Dec. 1, 2015, granted, now 10,751,519, issued on Aug. 25, 2020.
Application 14/955,109 is a continuation of application No. 14/253,127, filed on Apr. 15, 2014, granted, now 9,333,328, issued on May 10, 2016.
Application 14/253,127 is a continuation of application No. 13/884,169, granted, now 9,017,359, issued on Apr. 28, 2015, previously published as PCT/US2011/061815, filed on Nov. 22, 2011.
Claims priority of provisional application 61/416,187, filed on Nov. 22, 2010.
Prior Publication US 2022/0362527 A1, Nov. 17, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. A61M 25/10 (2013.01); A61M 25/04 (2006.01); A61M 29/02 (2006.01); A61M 60/135 (2021.01); A61M 60/295 (2021.01); A61M 60/405 (2021.01); A61M 60/497 (2021.01); A61M 60/531 (2021.01); A61M 60/869 (2021.01); A61M 60/122 (2021.01); A61M 60/17 (2021.01); A61M 60/274 (2021.01); A61M 60/40 (2021.01); A61M 60/50 (2021.01); A61M 60/562 (2021.01); A61M 60/857 (2021.01)
CPC A61M 29/02 (2013.01) [A61M 25/04 (2013.01); A61M 60/135 (2021.01); A61M 60/295 (2021.01); A61M 60/405 (2021.01); A61M 60/497 (2021.01); A61M 60/531 (2021.01); A61M 60/869 (2021.01); A61M 25/1018 (2013.01); A61M 25/10184 (2013.11); A61M 60/122 (2021.01); A61M 60/17 (2021.01); A61M 60/274 (2021.01); A61M 60/40 (2021.01); A61M 60/50 (2021.01); A61M 60/562 (2021.01); A61M 60/857 (2021.01); A61M 2205/33 (2013.01); A61M 2205/3303 (2013.01)] 22 Claims
OG exemplary drawing
 
1. A method for accessing implantable components for treating pulmonary hypertension, the method comprising:
accessing an anchor implanted in an expanded, deployed state wherein the anchor contacts an inner wall of the pulmonary artery to anchor a balloon coupled to a conduit within the pulmonary artery, the balloon configured to be pressurized with a fluid such that the balloon transitions between an expanded state and a contracted state responsive to pressure change in the pulmonary artery, wherein the fluid moves towards a reservoir coupled to the conduit when the balloon transitions to the contracted state and the fluid moves towards the balloon to expand the balloon to the expanded state; and
removing the conduit and the balloon while the anchor remains in the pulmonary artery.